{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T23:04:48Z","timestamp":1789859088928,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10585-018-9935-5","type":"journal-article","created":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T11:52:41Z","timestamp":1535802761000},"page":"707-712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1517-0603","authenticated-orcid":false,"given":"Verena","family":"Kirn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonie","family":"Strake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabinshy","family":"Thangarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Richters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Eischeid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Koitzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Odenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Fries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,1]]},"reference":[{"issue":"1","key":"9935_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3322\/caac.21203","volume":"64","author":"C DeSantis","year":"2014","unstructured":"DeSantis C, Ma J, Bryan L, Jemal A (2014) Breast cancer statistics, 2013. CA Cancer J Clin 64(1):52\u201362. \n                    https:\/\/doi.org\/10.3322\/caac.21203","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"9935_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1023\/A:1018778403001","volume":"3","author":"RG Lapidus","year":"1998","unstructured":"Lapidus RG, Nass SJ, Davidson NE (1998) The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 3(1):85\u201394","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"8","key":"9935_CR3","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1093\/oxfordjournals.aje.a117717","volume":"142","author":"PA Newcomb","year":"1995","unstructured":"Newcomb PA, Longnecker MP, Storer BE, Mittendorf R, Baron J, Clapp RW, Bogdan G, Willett WC (1995) Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol 142(8):788\u2013795","journal-title":"Am J Epidemiol"},{"key":"9935_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.ejca.2013.10.004","volume":"50","author":"G Aurilio","year":"2014","unstructured":"Aurilio G, Disalvatore D, Pruneri G, Bagnardi V, Viale G, Curigliano G, Adamoli L, Munzone E, Sciandivasci A, De Vita F, Goldhirsch A, Nol\u00e8 F (2014) A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. Eur J Cancer 50:277\u2013289. \n                    https:\/\/doi.org\/10.1016\/j.ejca.2013.10.004","journal-title":"Eur J Cancer"},{"issue":"19","key":"9935_CR5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/s12032-014-0214-2","volume":"31","author":"YF Yang","year":"2014","unstructured":"Yang YF, Liao YY, Yang M, Peng NF, Xie SR, Xie YF (2014) Discordances in ER, PR and HER2 receptors between primary and recurrent\/metastatic breast cancer patients. Med Oncol 31(19):214. \n                    https:\/\/doi.org\/10.1007\/s12032-014-0214-2","journal-title":"Med Oncol"},{"issue":"12","key":"9935_CR6","first-page":"2515","volume":"58","author":"RG Lapidus","year":"1998","unstructured":"Lapidus RG, Nass SJ, Butash KA, Parl FF, Weitzman SA, Graff JG, Herman JG, Davidson NE (1998) Mapping of ER gene CpG island methylation-specific polymerase chain reaction. Cancer Res 58(12):2515\u20132519","journal-title":"Cancer Res"},{"issue":"5","key":"9935_CR7","first-page":"805","volume":"2","author":"RG Lapidus","year":"1996","unstructured":"Lapidus RG, Ferguson AT, Ottaviano YL, Parl FE, Smith HS, Weitzman SA, Baylin SB, Issa JP, Davidson NE (1996) Methylation of estrogen and progesterone receptor gene 5CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumors. Clin Cancer Res 2(5):805\u2013810","journal-title":"Clin Cancer Res"},{"key":"9935_CR8","first-page":"5021","volume":"60","author":"CA Eads","year":"2000","unstructured":"Eads CA, Lord RV, Kurumboor SK, Wickramasinghe K, Skinner ML, Long TI, Peters JH, DeMeester TR, Danenberg KD, Danenberg PV, Laird PW, Skinner KA (2000) Fields of aberrant CpG island hypermethylation in Barrets`s esophagus and associated adenocarcinoma. Cancer Res 60:5021\u20135026","journal-title":"Cancer Res"},{"issue":"6","key":"9935_CR9","doi-asserted-by":"publisher","first-page":"958","DOI":"10.4161\/cbt.7.6.5966","volume":"7","author":"J Mart\u00ednez-Gal\u00e1n","year":"2008","unstructured":"Mart\u00ednez-Gal\u00e1n J, Torres B, Del Moral R, Mu\u00f1oz-G\u00e1mez JA, Mart\u00edn-Oliva D, Villalobos M, N\u00fa\u00f1ez MI, Luna Jde D, Oliver FJ, Ruiz de Almod\u00f3var JM (2008) Quantitative detection of methylated ESR1 and 14-3-3-sigma gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy. Cancer Biol Ther 7(6):958\u2013965","journal-title":"Cancer Biol Ther"},{"issue":"22","key":"9935_CR10","first-page":"7641","volume":"63","author":"HM M\u00fcller","year":"2003","unstructured":"M\u00fcller HM, Widschwendter A, Fiegl H, Ivarsson L, Goebel G, Perkmann E, Marth C, Widschwendter M (2003) DNA methylation in serum of breast cancer patients: an independent prognostic marker. Cancer Res 63(22):7641\u20137645","journal-title":"Cancer Res"},{"issue":"11","key":"9935_CR11","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1158\/0008-5472.CAN-03-3852","volume":"64","author":"M Widschwendter","year":"2004","unstructured":"Widschwendter M, Siegmund KD, M\u00fcller HM, Fiegl H, Marth C, M\u00fcller-Holzner E, Jones PA, Laird PW (2004) Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 64(11):3807\u20133813","journal-title":"Cancer Res"},{"key":"9935_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2407-10-23","volume":"10","author":"EA Ramos","year":"2010","unstructured":"Ramos EA, Camargo AA, Braun K, Slowik R, Cavalli IJ, Ribeiro EM, Pedrosa Fde O, de Souza EM, Costa FF, Klassen G (2010) Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer. BMC Cancer 10:23. \n                    https:\/\/doi.org\/10.1186\/1471-2407-10-23","journal-title":"BMC Cancer"},{"key":"9935_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/1471-2407-10-217","volume":"10","author":"M Zurita","year":"2010","unstructured":"Zurita M, Lara PC, del Moral R, Torres B, Linares-Fern\u00e1ndez JL, Arrabal SR, Mart\u00ednez-Gal\u00e1n J, Oliver FJ, Ruiz de Almod\u00f3var JM (2010) Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis. BMC Cancer 10:217. \n                    https:\/\/doi.org\/10.1186\/1471-2407-10-217","journal-title":"BMC Cancer"},{"issue":"3","key":"9935_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbrc.2017.06.117","volume":"490","author":"AM Jim\u00e9nez-Gardu\u00f1o","year":"2017","unstructured":"Jim\u00e9nez-Gardu\u00f1o AM, Mendoza-Rodr\u00edguez MG, Urrutia-Cabrera D, Dom\u00ednguez-Robles MC, P\u00e9rez-Y\u00e9pez EA, Ayala-Sumuano JT, Meza I (2017) IL-1\u03b2 induced methylation of the estrogen receptor ER\u03b1 gene correlates with EMT and chemoresistance in breast cancer cells. Biochem Biophys Res Commun 490(3):780\u2013785. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.117","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"9935_CR15","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.7314\/APJCP.2014.15.7.3041","volume":"15","author":"AD Medina-Jaime","year":"2014","unstructured":"Medina-Jaime AD, Reyes-Vargas F, Martinez-Gaytan V, Zambrano-Galvan G, Portillo-Delcampo E, Burciaga-Nava JA, Reyes-Romero M, Sifuentes-Alvarez A (2014) ESR1 and PGR gene promoter methylation and correlations with estrogen and progesterone receptors in ductal and lobular breast cancer. Asian Pac J Cancer Prev 15(7):3041\u20133044","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"9935_CR16","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1158\/1078-0432.CCR-17-1181","volume":"24","author":"S Mastoraki","year":"2018","unstructured":"Mastoraki S, Strati A, Tzanikou E, Chimonidou M, Politaki H, Voutsina A, Psyrri A, Georgoulias V, Lianidou ES (2018) ESR1 methylation: a liquid biopsy-based epigenetic assay for the follow up of patients with metastatic breast cancer receiving endocrine treatment. Clin Cancer Res 24(6):1500\u20131510. \n                    https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-1181","journal-title":"Clin Cancer Res"},{"issue":"1","key":"9935_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12885-017-3969-y","volume":"18","author":"SAM Urru","year":"2018","unstructured":"Urru SAM, Gallus S, Bosetti C, Moi T, Medda R, Sollai E, Murgia A, Sanges F, Pira G, Manca A, Palmas D, Floris M, Asunis AM, Atzori F, Carru C, D\u2019Incalci M, Ghiani M, Marras V, Onnis D, Santona MC, Sarobba G, Valle E, Canu L, Cossu S, Bulfone A, Rocca PC, De Miglio MR, Orr\u00f9 S (2018) Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients. BMC Cancer 18(1):56. \n                    https:\/\/doi.org\/10.1186\/s12885-017-3969-y","journal-title":"BMC Cancer"},{"key":"9935_CR18","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/1471-2407-13-456","volume":"13","author":"J Klajic","year":"2013","unstructured":"Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, L\u00f8nning PE, Solvang H, B\u00f8rresen-Dale AL, Tost J, Kristensen VN (2013) Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors. BMC Cancer 13:456. \n                    https:\/\/doi.org\/10.1186\/1471-2407-13-456","journal-title":"BMC Cancer"},{"key":"9935_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2407-14-59","volume":"14","author":"J Mart\u00ednez-Gal\u00e1n","year":"2014","unstructured":"Mart\u00ednez-Gal\u00e1n J, Torres-Torres B, N\u00fa\u00f1ez MI, L\u00f3pez-Pe\u00f1alver J, Del Moral R, Ruiz De Almod\u00f3var JM, Menj\u00f3n S, Concha A, Chamorro C, R\u00edos S, Delgado JR (2014) ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients. BMC Cancer 14:59. \n                    https:\/\/doi.org\/10.1186\/1471-2407-14-59","journal-title":"BMC Cancer"},{"key":"9935_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10549-007-9766-6","volume":"111","author":"M Wei","year":"2008","unstructured":"Wei M, Xu J, Dignam J, Nanda R, Sveen L, Fackenthal J, Grushko TA, Olopade OI (2008) Estrogen receptor a, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res Treat 111:113\u2013120. \n                    https:\/\/doi.org\/10.1007\/s10549-007-9766-6","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"9935_CR21","doi-asserted-by":"publisher","first-page":"621.638","DOI":"10.3233\/CBM-170697","volume":"21","author":"S Pirouzpanah","year":"2018","unstructured":"Pirouzpanah S, Taleban FA, Mehdipour P, Sabour S, Atri M (2018) Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER\/PR subtypes. Cancer Biomark 21(3):621.638. \n                    https:\/\/doi.org\/10.3233\/CBM-170697","journal-title":"Cancer Biomark"},{"key":"9935_CR22","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1158\/0008-5472.CAN-03-3852","volume":"64","author":"M Widschwendter","year":"2004","unstructured":"Widschwendter M, Siegmund KD, M\u00fcller HM, Fiegl H, Marth C, M\u00fcller-Holzner E, Jones PA, Laird PW (2004) Association of breast cancer DNA methylation profiles with hormone receptor and response to tamoxifen. Cancer Res 64:3807\u20133813","journal-title":"Cancer Res"},{"key":"9935_CR23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","volume":"70","author":"M Kulis","year":"2010","unstructured":"Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27\u201356","journal-title":"Adv Genet"},{"key":"9935_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-1804-1_1","volume":"1238","author":"R Kanwal","year":"2015","unstructured":"Kanwal R, Gupta K, Gupta S (2015) Cancer epigenetics: an introduction. Methods Mol Biol 1238:3\u201325","journal-title":"Methods Mol Biol"},{"issue":"1","key":"9935_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11910-014-0507-z","volume":"15","author":"JW Taylor","year":"2015","unstructured":"Taylor JW, Schiff D (2015) Treatment considerations for MGMT-unmethylated glioblastoma. Curr Neurol Rep 15(1):507","journal-title":"Curr Neurol Rep"},{"key":"9935_CR26","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1477-7819-12-93","volume":"12","author":"Q Qu","year":"2014","unstructured":"Qu Q, Zong Y, Fei XC, Chen XS, Xu C, Lou GY, Shen KW (2014) The importance of biopsy in clinically diagnosed metastatic lesions in patients with breast cancer. World J Surg Oncol 12:93. \n                    https:\/\/doi.org\/10.1186\/1477-7819-12-93","journal-title":"World J Surg Oncol"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-018-9935-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-018-9935-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T20:04:19Z","timestamp":1567281859000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-018-9935-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["9935"],"URL":"https:\/\/doi.org\/10.1007\/s10585-018-9935-5","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]},"assertion":[{"value":"21 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}